Press Releases



Mediclinic Intnl plc - Completion of Successful Refinancing

28/06/2016
RNS Number : 5342C
Mediclinic International PLC
28 June 2016
 

Mediclinic International plc 
(Incorporated in England and Wales)
Company Number: 08338604
LSE Share Code: MDC

JSE Share Code: MEI
NSX Share Code: MEP

ISIN: GB00B8HX8Z88

 

28 June 2016

 

Mediclinic International plc Completes Successful Refinancing

 

Mediclinic International plc ("Mediclinic" or the "Company"), a leading international private healthcare group, is pleased to announce completion of the refinancing of the Mediclinic Bridge Facility associated with the Company's combination with Al Noor Hospitals Group plc.

 

Summary of new facilities:

 

·      South African senior bank loan totalling ZAR1.2 billion at an interest rate of JIBAR +1.69% with a 3-year term expiring in June 2019

·      South African unsecured preference share funding totalling ZAR1.5 billion at a rate of 73% of the prime overdraft interest rate, with a 4-year term expiring in June 2020

·      United Arab Emirates bank loans of $54.5 million and $100.0 million at an interest rate of LIBOR + 2.75% with respective 4-year and 5-year amortising terms, expiring in June 2020 and May 2021

 

The remainder of the £266 million drawn down from the Mediclinic Bridge Facility has been satisfied by a $64.5 million payment from existing cash resources.

 

Registered address: 1st Floor, 40 Dukes Place, London, EC3A 7NH, United Kingdom

 

Website: www.mediclinic.com

 

JSE sponsor: RAND MERCHANT BANK (A division of FirstRand Bank Limited)

 

NSX sponsor: Simonis Storm Securities (Pty) Ltd

 

 

For further information, please contact:

 

Company Secretary:

Victoria Dalby              

Capita Company Secretarial Services Limited

+44 (0)207 954 9600

 

UK:

Liz Morley /Aarti Iyer/Lucy Stewart

Bell Pottinger

+44 (0)203 772 2468

 

South Africa:

Tertia Kruger

Mediclinic International

+27 21 809 6500

 

Notes:

 

Mediclinic is the world's third largest listed acute hospital operator (outside of the United States), with three operating platforms in Southern Africa (South Africa and Namibia), Switzerland and the United Arab Emirates. Its core purpose is to enhance the quality of life of patients by providing cost-effective acute care specialised hospital services. The group operates 73 hospitals and 45 clinics.

 

Mediclinic also holds a 29.9% interest in Spire Healthcare, a LSE-listed private healthcare group based in the UK.

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBSGDLIDDBGLI